ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pressurized Metered-dose Inhaler Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-23B1661
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Pressurized Metered dose Inhaler Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pressurized Metered-dose Inhaler Market Research Report 2025

Code: QYRE-Auto-23B1661
Report
August 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck& Co. Inc
Glenmark Pharmaceuticals (India)
Novartis International AG (Switzerland)
Propeller Health (USA)
AstraZeneca Plc (Sweden)
Philips Respironics (Netherlands)
Teva Pharmaceutical Industries （Israel）
Opko Health (USA)
Merck (USA)
BioCare Group （Malaysia）

Pressurized Metered-dose Inhaler Market Size

The global market for Pressurized Metered-dose Inhaler was valued at US$ 6400 million in the year 2024 and is projected to reach a revised size of US$ 7816 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Pressurized Metered-dose Inhaler Market

Pressurized Metered-dose Inhaler Market

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pressurized Metered-dose Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pressurized Metered-dose Inhaler.
The Pressurized Metered-dose Inhaler market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pressurized Metered-dose Inhaler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pressurized Metered-dose Inhaler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pressurized Metered-dose Inhaler Market Report

Report Metric Details
Report Name Pressurized Metered-dose Inhaler Market
Accounted market size in year US$ 6400 million
Forecasted market size in 2031 US$ 7816 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Single-dose Inhalers
  • Multi-dose Inhalers
Segment by Application
  • Hospitals
  • Ambulatory Surgery Centres
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Glenmark Pharmaceuticals(India), Novartis International AG(Switzerland), Propeller Health(USA), AstraZeneca Plc(Sweden), Philips Respironics(Netherlands), Teva Pharmaceutical Industries(Israel), Opko Health(USA), Merck(USA), BioCare Group(Malaysia)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pressurized Metered-dose Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pressurized Metered-dose Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pressurized Metered-dose Inhaler Market growing?

Ans: The Pressurized Metered-dose Inhaler Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Pressurized Metered-dose Inhaler Market size in 2031?

Ans: The Pressurized Metered-dose Inhaler Market size in 2031 will be US$ 7816 million.

What is the Pressurized Metered-dose Inhaler Market share by region?

Ans: North America is the largest market, with a market share nearly 44.49% in 2019.

Who are the main players in the Pressurized Metered-dose Inhaler Market report?

Ans: The main players in the Pressurized Metered-dose Inhaler Market are Glenmark Pharmaceuticals(India), Novartis International AG(Switzerland), Propeller Health(USA), AstraZeneca Plc(Sweden), Philips Respironics(Netherlands), Teva Pharmaceutical Industries(Israel), Opko Health(USA), Merck(USA), BioCare Group(Malaysia)

What are the Application segmentation covered in the Pressurized Metered-dose Inhaler Market report?

Ans: The Applications covered in the Pressurized Metered-dose Inhaler Market report are Hospitals, Ambulatory Surgery Centres

What are the Type segmentation covered in the Pressurized Metered-dose Inhaler Market report?

Ans: The Types covered in the Pressurized Metered-dose Inhaler Market report are Single-dose Inhalers, Multi-dose Inhalers

1 Pressurized Metered-dose Inhaler Market Overview
1.1 Product Definition
1.2 Pressurized Metered-dose Inhaler by Type
1.2.1 Global Pressurized Metered-dose Inhaler Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single-dose Inhalers
1.2.3 Multi-dose Inhalers
1.3 Pressurized Metered-dose Inhaler by Application
1.3.1 Global Pressurized Metered-dose Inhaler Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centres
1.4 Global Pressurized Metered-dose Inhaler Market Size Estimates and Forecasts
1.4.1 Global Pressurized Metered-dose Inhaler Revenue 2020-2031
1.4.2 Global Pressurized Metered-dose Inhaler Sales 2020-2031
1.4.3 Global Pressurized Metered-dose Inhaler Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pressurized Metered-dose Inhaler Market Competition by Manufacturers
2.1 Global Pressurized Metered-dose Inhaler Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pressurized Metered-dose Inhaler Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pressurized Metered-dose Inhaler Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pressurized Metered-dose Inhaler, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pressurized Metered-dose Inhaler, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pressurized Metered-dose Inhaler, Product Type & Application
2.7 Global Key Manufacturers of Pressurized Metered-dose Inhaler, Date of Enter into This Industry
2.8 Global Pressurized Metered-dose Inhaler Market Competitive Situation and Trends
2.8.1 Global Pressurized Metered-dose Inhaler Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pressurized Metered-dose Inhaler Players Market Share by Revenue
2.8.3 Global Pressurized Metered-dose Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pressurized Metered-dose Inhaler Market Scenario by Region
3.1 Global Pressurized Metered-dose Inhaler Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pressurized Metered-dose Inhaler Sales by Region: 2020-2031
3.2.1 Global Pressurized Metered-dose Inhaler Sales by Region: 2020-2025
3.2.2 Global Pressurized Metered-dose Inhaler Sales by Region: 2026-2031
3.3 Global Pressurized Metered-dose Inhaler Revenue by Region: 2020-2031
3.3.1 Global Pressurized Metered-dose Inhaler Revenue by Region: 2020-2025
3.3.2 Global Pressurized Metered-dose Inhaler Revenue by Region: 2026-2031
3.4 North America Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.4.1 North America Pressurized Metered-dose Inhaler Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pressurized Metered-dose Inhaler Sales by Country (2020-2031)
3.4.3 North America Pressurized Metered-dose Inhaler Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.5.1 Europe Pressurized Metered-dose Inhaler Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pressurized Metered-dose Inhaler Sales by Country (2020-2031)
3.5.3 Europe Pressurized Metered-dose Inhaler Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pressurized Metered-dose Inhaler Market Facts & Figures by Region
3.6.1 Asia Pacific Pressurized Metered-dose Inhaler Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pressurized Metered-dose Inhaler Sales by Region (2020-2031)
3.6.3 Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.7.1 Latin America Pressurized Metered-dose Inhaler Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pressurized Metered-dose Inhaler Sales by Country (2020-2031)
3.7.3 Latin America Pressurized Metered-dose Inhaler Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.8.1 Middle East and Africa Pressurized Metered-dose Inhaler Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pressurized Metered-dose Inhaler Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pressurized Metered-dose Inhaler Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pressurized Metered-dose Inhaler Sales by Type (2020-2031)
4.1.1 Global Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
4.1.2 Global Pressurized Metered-dose Inhaler Sales by Type (2026-2031)
4.1.3 Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2020-2031)
4.2 Global Pressurized Metered-dose Inhaler Revenue by Type (2020-2031)
4.2.1 Global Pressurized Metered-dose Inhaler Revenue by Type (2020-2025)
4.2.2 Global Pressurized Metered-dose Inhaler Revenue by Type (2026-2031)
4.2.3 Global Pressurized Metered-dose Inhaler Revenue Market Share by Type (2020-2031)
4.3 Global Pressurized Metered-dose Inhaler Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pressurized Metered-dose Inhaler Sales by Application (2020-2031)
5.1.1 Global Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
5.1.2 Global Pressurized Metered-dose Inhaler Sales by Application (2026-2031)
5.1.3 Global Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2031)
5.2 Global Pressurized Metered-dose Inhaler Revenue by Application (2020-2031)
5.2.1 Global Pressurized Metered-dose Inhaler Revenue by Application (2020-2025)
5.2.2 Global Pressurized Metered-dose Inhaler Revenue by Application (2026-2031)
5.2.3 Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2020-2031)
5.3 Global Pressurized Metered-dose Inhaler Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Glenmark Pharmaceuticals(India)
6.1.1 Glenmark Pharmaceuticals(India) Company Information
6.1.2 Glenmark Pharmaceuticals(India) Description and Business Overview
6.1.3 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product Portfolio
6.1.5 Glenmark Pharmaceuticals(India) Recent Developments/Updates
6.2 Novartis International AG(Switzerland)
6.2.1 Novartis International AG(Switzerland) Company Information
6.2.2 Novartis International AG(Switzerland) Description and Business Overview
6.2.3 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product Portfolio
6.2.5 Novartis International AG(Switzerland) Recent Developments/Updates
6.3 Propeller Health(USA)
6.3.1 Propeller Health(USA) Company Information
6.3.2 Propeller Health(USA) Description and Business Overview
6.3.3 Propeller Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Propeller Health(USA) Pressurized Metered-dose Inhaler Product Portfolio
6.3.5 Propeller Health(USA) Recent Developments/Updates
6.4 AstraZeneca Plc(Sweden)
6.4.1 AstraZeneca Plc(Sweden) Company Information
6.4.2 AstraZeneca Plc(Sweden) Description and Business Overview
6.4.3 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product Portfolio
6.4.5 AstraZeneca Plc(Sweden) Recent Developments/Updates
6.5 Philips Respironics(Netherlands)
6.5.1 Philips Respironics(Netherlands) Company Information
6.5.2 Philips Respironics(Netherlands) Description and Business Overview
6.5.3 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product Portfolio
6.5.5 Philips Respironics(Netherlands) Recent Developments/Updates
6.6 Teva Pharmaceutical Industries(Israel)
6.6.1 Teva Pharmaceutical Industries(Israel) Company Information
6.6.2 Teva Pharmaceutical Industries(Israel) Description and Business Overview
6.6.3 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product Portfolio
6.6.5 Teva Pharmaceutical Industries(Israel) Recent Developments/Updates
6.7 Opko Health(USA)
6.7.1 Opko Health(USA) Company Information
6.7.2 Opko Health(USA) Description and Business Overview
6.7.3 Opko Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Opko Health(USA) Pressurized Metered-dose Inhaler Product Portfolio
6.7.5 Opko Health(USA) Recent Developments/Updates
6.8 Merck(USA)
6.8.1 Merck(USA) Company Information
6.8.2 Merck(USA) Description and Business Overview
6.8.3 Merck(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck(USA) Pressurized Metered-dose Inhaler Product Portfolio
6.8.5 Merck(USA) Recent Developments/Updates
6.9 BioCare Group(Malaysia)
6.9.1 BioCare Group(Malaysia) Company Information
6.9.2 BioCare Group(Malaysia) Description and Business Overview
6.9.3 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product Portfolio
6.9.5 BioCare Group(Malaysia) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pressurized Metered-dose Inhaler Industry Chain Analysis
7.2 Pressurized Metered-dose Inhaler Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pressurized Metered-dose Inhaler Production Mode & Process Analysis
7.4 Pressurized Metered-dose Inhaler Sales and Marketing
7.4.1 Pressurized Metered-dose Inhaler Sales Channels
7.4.2 Pressurized Metered-dose Inhaler Distributors
7.5 Pressurized Metered-dose Inhaler Customer Analysis
8 Pressurized Metered-dose Inhaler Market Dynamics
8.1 Pressurized Metered-dose Inhaler Industry Trends
8.2 Pressurized Metered-dose Inhaler Market Drivers
8.3 Pressurized Metered-dose Inhaler Market Challenges
8.4 Pressurized Metered-dose Inhaler Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck& Co. Inc
Glenmark Pharmaceuticals (India)
Novartis International AG (Switzerland)
Propeller Health (USA)
AstraZeneca Plc (Sweden)
Philips Respironics (Netherlands)
Teva Pharmaceutical Industries （Israel）
Opko Health (USA)
Merck (USA)
BioCare Group （Malaysia）
List of Tables
 Table 1. Global Pressurized Metered-dose Inhaler Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pressurized Metered-dose Inhaler Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pressurized Metered-dose Inhaler Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pressurized Metered-dose Inhaler Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pressurized Metered-dose Inhaler Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pressurized Metered-dose Inhaler Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pressurized Metered-dose Inhaler Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pressurized Metered-dose Inhaler, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pressurized Metered-dose Inhaler, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pressurized Metered-dose Inhaler, Product Type & Application
 Table 12. Global Key Manufacturers of Pressurized Metered-dose Inhaler, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pressurized Metered-dose Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pressurized Metered-dose Inhaler as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pressurized Metered-dose Inhaler Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pressurized Metered-dose Inhaler Sales by Region (2020-2025) & (Units)
 Table 18. Global Pressurized Metered-dose Inhaler Sales Market Share by Region (2020-2025)
 Table 19. Global Pressurized Metered-dose Inhaler Sales by Region (2026-2031) & (Units)
 Table 20. Global Pressurized Metered-dose Inhaler Sales Market Share by Region (2026-2031)
 Table 21. Global Pressurized Metered-dose Inhaler Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pressurized Metered-dose Inhaler Revenue Market Share by Region (2020-2025)
 Table 23. Global Pressurized Metered-dose Inhaler Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pressurized Metered-dose Inhaler Revenue Market Share by Region (2026-2031)
 Table 25. North America Pressurized Metered-dose Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
 Table 27. North America Pressurized Metered-dose Inhaler Sales by Country (2026-2031) & (Units)
 Table 28. North America Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pressurized Metered-dose Inhaler Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pressurized Metered-dose Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
 Table 32. Europe Pressurized Metered-dose Inhaler Sales by Country (2026-2031) & (Units)
 Table 33. Europe Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pressurized Metered-dose Inhaler Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pressurized Metered-dose Inhaler Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Pressurized Metered-dose Inhaler Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pressurized Metered-dose Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Pressurized Metered-dose Inhaler Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pressurized Metered-dose Inhaler Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pressurized Metered-dose Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Pressurized Metered-dose Inhaler Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pressurized Metered-dose Inhaler Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pressurized Metered-dose Inhaler Sales (Units) by Type (2020-2025)
 Table 51. Global Pressurized Metered-dose Inhaler Sales (Units) by Type (2026-2031)
 Table 52. Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2020-2025)
 Table 53. Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2026-2031)
 Table 54. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pressurized Metered-dose Inhaler Revenue Market Share by Type (2020-2025)
 Table 57. Global Pressurized Metered-dose Inhaler Revenue Market Share by Type (2026-2031)
 Table 58. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Pressurized Metered-dose Inhaler Sales (Units) by Application (2020-2025)
 Table 61. Global Pressurized Metered-dose Inhaler Sales (Units) by Application (2026-2031)
 Table 62. Global Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
 Table 63. Global Pressurized Metered-dose Inhaler Sales Market Share by Application (2026-2031)
 Table 64. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2020-2025)
 Table 67. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2026-2031)
 Table 68. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Application (2026-2031)
 Table 70. Glenmark Pharmaceuticals(India) Company Information
 Table 71. Glenmark Pharmaceuticals(India) Description and Business Overview
 Table 72. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product
 Table 74. Glenmark Pharmaceuticals(India) Recent Developments/Updates
 Table 75. Novartis International AG(Switzerland) Company Information
 Table 76. Novartis International AG(Switzerland) Description and Business Overview
 Table 77. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product
 Table 79. Novartis International AG(Switzerland) Recent Developments/Updates
 Table 80. Propeller Health(USA) Company Information
 Table 81. Propeller Health(USA) Description and Business Overview
 Table 82. Propeller Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Propeller Health(USA) Pressurized Metered-dose Inhaler Product
 Table 84. Propeller Health(USA) Recent Developments/Updates
 Table 85. AstraZeneca Plc(Sweden) Company Information
 Table 86. AstraZeneca Plc(Sweden) Description and Business Overview
 Table 87. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product
 Table 89. AstraZeneca Plc(Sweden) Recent Developments/Updates
 Table 90. Philips Respironics(Netherlands) Company Information
 Table 91. Philips Respironics(Netherlands) Description and Business Overview
 Table 92. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product
 Table 94. Philips Respironics(Netherlands) Recent Developments/Updates
 Table 95. Teva Pharmaceutical Industries(Israel) Company Information
 Table 96. Teva Pharmaceutical Industries(Israel) Description and Business Overview
 Table 97. Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product
 Table 99. Teva Pharmaceutical Industries(Israel) Recent Developments/Updates
 Table 100. Opko Health(USA) Company Information
 Table 101. Opko Health(USA) Description and Business Overview
 Table 102. Opko Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Opko Health(USA) Pressurized Metered-dose Inhaler Product
 Table 104. Opko Health(USA) Recent Developments/Updates
 Table 105. Merck(USA) Company Information
 Table 106. Merck(USA) Description and Business Overview
 Table 107. Merck(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Merck(USA) Pressurized Metered-dose Inhaler Product
 Table 109. Merck(USA) Recent Developments/Updates
 Table 110. BioCare Group(Malaysia) Company Information
 Table 111. BioCare Group(Malaysia) Description and Business Overview
 Table 112. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product
 Table 114. BioCare Group(Malaysia) Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Pressurized Metered-dose Inhaler Distributors List
 Table 118. Pressurized Metered-dose Inhaler Customers List
 Table 119. Pressurized Metered-dose Inhaler Market Trends
 Table 120. Pressurized Metered-dose Inhaler Market Drivers
 Table 121. Pressurized Metered-dose Inhaler Market Challenges
 Table 122. Pressurized Metered-dose Inhaler Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pressurized Metered-dose Inhaler
 Figure 2. Global Pressurized Metered-dose Inhaler Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pressurized Metered-dose Inhaler Market Share by Type: 2024 & 2031
 Figure 4. Single-dose Inhalers Product Picture
 Figure 5. Multi-dose Inhalers Product Picture
 Figure 6. Global Pressurized Metered-dose Inhaler Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pressurized Metered-dose Inhaler Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Ambulatory Surgery Centres
 Figure 10. Global Pressurized Metered-dose Inhaler Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pressurized Metered-dose Inhaler Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pressurized Metered-dose Inhaler Sales (2020-2031) & (Units)
 Figure 13. Global Pressurized Metered-dose Inhaler Average Price (USD/Unit) & (2020-2031)
 Figure 14. Pressurized Metered-dose Inhaler Report Years Considered
 Figure 15. Pressurized Metered-dose Inhaler Sales Share by Manufacturers in 2024
 Figure 16. Global Pressurized Metered-dose Inhaler Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pressurized Metered-dose Inhaler Players: Market Share by Revenue in Pressurized Metered-dose Inhaler in 2024
 Figure 18. Pressurized Metered-dose Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pressurized Metered-dose Inhaler Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2031)
 Figure 21. North America Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pressurized Metered-dose Inhaler Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pressurized Metered-dose Inhaler Revenue Market Share by Region (2020-2031)
 Figure 33. China Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Pressurized Metered-dose Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Pressurized Metered-dose Inhaler by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Pressurized Metered-dose Inhaler by Type (2020-2031)
 Figure 55. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Pressurized Metered-dose Inhaler by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Pressurized Metered-dose Inhaler by Application (2020-2031)
 Figure 58. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Application (2020-2031)
 Figure 59. Pressurized Metered-dose Inhaler Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Medical Pressurized Metered Dose Inhalers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhaler Devices for Respiratory Medicines Market Research Report 2024
Global Inhalation Drug Delivery Devices Market Research Report 2024
Global Inhaler Devices Market Insights Forecast to 2030
Global Asthma Inhalation Formulation Market Research Report 2024
Global Breath actuated Inhaler Market Research Report 2025
Global Corticosteroids Inhalation Formulation Market Research Report 2024
Global Medical Metered Dose Inhaler Market Research Report 2025
Global Multi Dose Dry Powder Inhaler Device Market Research Report 2025
Global Metered Dose Inhaler Devices Market Research Report 2025
Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Nebulizer Devices Market Research Report 2025
Drug Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalers and Nebulizers Market Research Report 2025
Global COPD and Asthma Drug Devices Market Insights Forecast to 2030
Global Metered Dose Medical Spray Pump Market Research Report 2024
Global COPD Inhaler Market Research Report 2025
Global Medical Nebulizer Market Research Report 2025
Global Devices for Inhaled Medications Market Research Report 2025
Global High Pressure Nebuliser Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions